Goldman Sachs Group Inc Ptc Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 822,441 shares of PTCT stock, worth $32.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

822,441

Previous 791,164 3.95%

Holding current value

$32.3 Million

Previous $24.2 Million 26.12%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $950,508 - $1.18 Million	31,277 Added 3.95%	822,441 $30.5 Million
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $7.68 Million - $12.5 Million	311,143 Added 64.82%	791,164 $24.2 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $1.12 Million - $1.48 Million	-46,473 Reduced 8.83%	480,021 $14 Million
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $3.37 Million - $5.48 Million	186,608 Added 54.9%	526,494 $14.5 Million
Q3 2023 May 14, 2024	SELL	$22.41 - $41.99 $4.18 Million - $7.84 Million	-186,608 Reduced 35.44%	339,886 $7.62 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $1.94 Million - $3.63 Million	-86,346 Reduced 20.26%	339,886 $7.62 Million
Q2 2023 May 14, 2024	SELL	$40.4 - $59.1 $1.07 Million - $1.56 Million	-26,450 Reduced 5.84%	426,232 $17.3 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $1.07 Million - $1.56 Million	-26,450 Reduced 5.84%	426,232 $17.3 Million
Q1 2023 May 14, 2024	SELL	$38.16 - $48.86 $3.07 Million - $3.93 Million	-80,352 Reduced 15.07%	452,682 $21.9 Million
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $3.07 Million - $3.93 Million	-80,352 Reduced 15.07%	452,682 $21.9 Million
Q4 2022 May 14, 2024	BUY	$33.53 - $54.79 $923,952 - $1.51 Million	27,556 Added 5.45%	533,034 $20.3 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $923,952 - $1.51 Million	27,556 Added 5.45%	533,034 $20.3 Million
Q3 2022 May 14, 2024	BUY	$41.85 - $53.85 $389,121 - $500,697	9,298 Added 1.87%	505,478 $25.4 Million
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $389,121 - $500,697	9,298 Added 1.87%	505,478 $25.4 Million
Q2 2022 May 14, 2024	SELL	$25.6 - $45.23 $776,038 - $1.37 Million	-30,314 Reduced 5.76%	496,180 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $6.85 Million - $12.1 Million	267,773 Added 117.24%	496,180 $19.9 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $9.96 Million - $13.3 Million	-298,926 Reduced 56.69%	228,407 $8.52 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $10.6 Million - $12.5 Million	299,114 Added 131.06%	527,333 $21 Million
Q3 2021 Nov 10, 2021	BUY	$37.01 - $44.74 $8.45 Million - $10.2 Million	228,219 New	228,219 $8.49 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Ptc Therapeutics, Inc. Transaction History